Imaging of glioma MPI/Uni Cologne Karl Herholz Wolfson Molecular Imaging Centre Manchester, UK 33 rd ESMO Congress, Stockholm Sept 14-16, 2008 Karl Herholz Wolfson Molecular…

Zurich Open Repository and Archive University of Zurich University Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2012 The impact of chemotherapy on cognitive

Low Grade GliomaAhmed Ammar Department of Neurosurgery, Dammam University, Al Khobar, Saudi Arabia • Is it always benign? • What is the prognosis? are present features

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade GliomasReviewed by: Maarten Wijnenga, National Cancer Center Hospital, Japan *Correspondence:

Molecular Classification of Low-Grade Diffuse GliomasYoung-Ho Kim,* Sumihito Nobusawa,*† Michel Mittelbronn,‡ Werner Paulus,§ Benjamin Brokinkel,¶

Presentación de PowerPointHospital Universitario Regional y Virgen de la Victoria, Málaga, Spain Maximal safe MRI < 72h Molecular Markers 1p 19q IDH1-R132H

240 histologic subtypes, as well as significant differences between spinal cord tumors and brain tumors of the same histologic type12). Genetic heterogeneity has also been

Oligodendroglioma: pathology, molecular mechanisms and markersREVIEW Pieter Wesseling1,2 · Martin van den Bent3 · Arie Perry4 Received: 12 March 2015 / Revised:

Oligodendrogliomas en el Instituto Nacional de Neurología y Neurocirugía: comportamiento biológico en una población definida140 Oligodendrogliomas

Differentiation betweenOligodendroglioma Genotypes Using Dynamic Susceptibility Contrast Perfusion-Weighted Imaging and ProtonMR Spectroscopy S. Chawla, J. Krejza, A. Vossough,